SAN FRANCISCO, Sept. 12, 2024 (GLOBE NEWSWIRE) -- Hagens Berman urges DexCom, Inc. (NASDAQ: DXCM) investors who suffered substantial losses to submit your losses now. The firm also encourages persons with knowledge who may be able to assist in the investigation to contact its attorneys. On July 26, 2024, the price of DexCom shares cratered $43.85 (-40%) after the company announced Q2 2024 financial results and outlook that significantly disappointed investors and analysts. Unsurprisingly, downgrades followe ...